Oramed Pharmaceuticals Inc.

_________ false


	Israel Securities Authority			Tel Aviv Stock Exchange		C310 ( Public )		Reported via MAGNA:	23/07/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-063322	Time of broadcast: 17:33 17:32:51

Initial Details of the Corporation�s Securities and the Corporation�s Capital

As of the date of this report, the share capital of the corporation is as follows:1


Class of share:	Common stock

Registered capital: 30,000,000

Issued capital: 13,320,962


Currency: USD	_________

Stock exchange on which securities are listed for trade: NASDAQ CM

Number of securities on stock exchange: _________

The following are details of additional securities that were issued by the corporation:1


Class of security:	_________

Series: _________


Period of conversion / realization (if aplicable):	_________


The stock exchange on which the security is listed for trade:	_________

Number of security on the stock exchange: _________

Type of shares that will derive from realization / conversion of the security (if aplicable): _________

Quantity of shares that will derive from full realization / conversion (if aplicable): _________

Number on the stock exchange of the share derive from realization / conversion of the security (if aplicable): _________



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 16/07/2017
Address: Hi-tech Park, Givat Ram 2/4 p.o.b 39098 , Jerusalem 91390 , Israel Tel: 02-5660001 , 02-5788763 Fax: 02-5660004
E-mail address: [email protected] Company site: www.ermed.com

Previous names of reporting entity:

Name of the Signatory: ZOMMER YIFAT HEN Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company: .Oramed Ltd
Address: Hi-tech Park, Givat Ram 2/4 p.o.b 39098 , Jerusalem 91390 Telephone: 02-5788763 Facsimile: 02-5660004 E-mail: [email protected] 2
Israel

AI Terminal